Anesthesia Management in Redo Mitral Valve Replacement Surgery in a Patient with a Rare Blood Group: A Case Report

Simple item page
AuthorRasoul Azarfarinen
AuthorMohsen Ziyaeifarden
AuthorAzin Alizadehaslen
AuthorKamran Roudinien
AuthorFatemehshima Hadipourzadehen
AuthorJavad Jamalianen
OrcidRasoul Azarfarin [0000-0001-9630-7303]en
OrcidMohsen Ziyaeifard [0000-0002-5631-4813]en
OrcidAzin Alizadehasl [0000-0002-8550-1378]en
OrcidKamran Roudini [0000-0003-0166-0505]en
OrcidFatemehshima Hadipourzadeh [0000-0003-2777-3014]en
OrcidJavad Jamalian [0000-0003-3694-4874]en
Issued Date2022-06-30en
AbstractIntroduction: One of the conditions leading to hemolysis in patients with artificial metallic heart valves is valvular dysfunction. In case of symptomatic hemolysis, a blood transfusion may be needed along with standard treatments. Inattention to the differential diagnosis of hemolysis and making decisions based on causes that are more obvious can lead to incorrect approaches. Case Presentation: In this case report, we presented a case with a previously undiagnosed rare blood group (positive antibody anti-E, anti-c, anti-Kell), undergoing reoperation of mitral valve replacement (MVR), who developed severe hemolysis and subsequent acute renal failure secondary to incompatible blood transfusion and required hemodialysis. Conclusions: In this patient, hemolysis was solely attributed to mitral valve dysfunction. By timely diagnosis of the subtype of her blood group and appropriate decision-making during surgery, adverse blood transfusion outcomes were prevented.en
DOIhttps://doi.org/10.5812/aapm-124213en
PublisherBrieflandsen
TitleAnesthesia Management in Redo Mitral Valve Replacement Surgery in a Patient with a Rare Blood Group: A Case Reporten
TypeCase Reporten

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
aapm-12-3-124213.pdf
Size:
80.12 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF
Download

Collections

Anesthesiology and Pain Medicine